Mattern Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Mattern Wealth Management's NVS Position: Q2 2026 in Review
Mattern Wealth Management increased its Novartis (NVS) stake by 2.1% in Q2 2026, buying an estimated $4.95K and bringing the position to 1,633 shares worth $256K. The position accounts for 0.04% of the portfolio, ranked #160.
Mattern Wealth Management first reported a position in NVS in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.14M in Q2 2020. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Mattern Wealth Management held 1,633 shares of Novartis worth $256K as of Q2 2026.
- Mattern Wealth Management bought 33 Novartis shares in Q2 2026, an estimated $4.95K.
- Novartis made up 0.04% of Mattern Wealth Management's portfolio in Q2 2026, its #160 holding.
- Mattern Wealth Management first reported a position in Novartis in Q4 2019 and has held it in 25 quarters since.
- Mattern Wealth Management's Novartis position peaked at $1.14M in Q2 2020.
- 1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Mattern Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.